Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,336 | -16,537 | -104,527 | -57,537 | -47,066 |
| Depreciation Amortization | 23,285 | 12,009 | 72,082 | 54,328 | 38,722 |
| Income taxes - deferred | 336 | 141 | -535 | -2,452 | -4,646 |
| Accounts receivable | 1,677 | -778 | -7,685 | -6,695 | -9,872 |
| Accounts payable and accrued liabilities | 5,726 | -3,483 | 8,909 | 21,875 | 12,828 |
| Other Working Capital | 5,729 | -6,671 | -4,391 | -4,500 | -2,036 |
| Other Operating Activity | 19,019 | 18,059 | 63,038 | 16,096 | 21,745 |
| Operating Cash Flow | $32,436 | $2,740 | $26,891 | $21,115 | $9,675 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76 | -71 | -1,503 | -147 | -79 |
| Purchase Sale Intangibles | -722 | -416 | -963 | -298 | N/A |
| Other Investing Activity | -720 | -415 | -876 | -212 | 85 |
| Investing Cash Flow | $-796 | $-486 | $-2,379 | $-359 | $6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -175 | -175 | 37,927 | N/A | N/A |
| Other Financing Activity | -6,573 | -1,681 | -11,899 | -7,036 | -5,517 |
| Financing Cash Flow | $-6,748 | $-1,856 | $26,028 | $-7,036 | $-5,517 |
| Exchange Rate Effect | -744 | -645 | 1,029 | -5,567 | -4,267 |
| Beginning Cash Position | 118,798 | 118,769 | 67,229 | 67,229 | 67,229 |
| End Cash Position | 142,946 | 118,522 | 118,798 | 75,382 | 67,126 |
| Net Cash Flow | $-24,148 | $-247 | $51,569 | $8,153 | $-103 |
| Free Cash Flow | |||||
| Operating Cash Flow | 32,436 | 2,740 | 26,891 | 21,115 | 9,675 |
| Capital Expenditure | -76 | -71 | -1,503 | -147 | -79 |
| Free Cash Flow | 32,360 | 2,669 | 25,388 | 20,968 | 9,596 |